Advertisement

Topics

Latest "Finish Line" News Stories

01:16 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Finish Line" found in our extensive news archives from over 250 global news sources.

More Information about Finish Line on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Finish Line for you to read. Along with our medical data and news we also list Finish Line Clinical Trials, which are updated daily. BioPortfolio also has a large database of Finish Line Companies for you to search.

Showing "Finish Line" News Articles 1–25 of 3,600+

Relevant

Changing the finish line: Syneos talks bringing payer, patient voice into drug development

The drug development âfinish lineâ is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.


ADMA Biologics: Finish Line Ahead?

Intercept And NASH: Itching To The Finish Line


Islet encapsulation therapy — racing towards the finish line?

BMS first to cross finish line in China PD-1 approval race

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments http://dlvr.it/Qlgk4c pic.twitter.com/2TZ1d85mtZ

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments http://dlvr.it/Qlgk4c  pic.twitter.com/2TZ1d85mtZ

Boehringer increases manufacturing capacity in China

By adding a new fill-and-finish line at its Shanghai site, the German drugmaker aims to be a "one-stop shop" for GMP contract manufacturing.

Read our previous coverage of how the laureates’ discoveries have impacted medicine: #Opdivo, the first PD-1 inhibitor, breezes across the finish line https://rdcu.be/8f4h ; investors pursue immuno-oncology startups https://rdcu.be/8f2Y 

Read our previous coverage of how the laureates’ discoveries have impacted medicine: #Opdivo, the first PD-1 inhibitor, breezes across the finish line https://rdcu.be/8f4h ; investors pursue immuno-oncology startups https://rdcu.be/8f2Y 

New Drugs Approved In May

The bench to bedside journey of drugs is no easy task. Some drug candidates fail to complete the journey while many make it to the finish line only after undergoing numerous obstacles.

Rentschler Fill Solutions, Ultragenyx in Fill/Finish Pact

Rentschler to provide fill/finish services for the U.S. commercial supply of Mepsevii

#jobs #lifescience Senior Project Engineer (Pharmaceutical – Fill-Finish)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Project Engineer (Pharmaceutical – Fill-Finish) .MA-Boston, Senior Project Engineer (Pharmaceutical – Fill-Finish) JD817737 Boston, MA area Summary: DPS Engineering is looking for a proven Senior Project Engineer … Continue reading → Cet article ...

How to Stop Abandoning Projects

Dr. Ellen Hendriksen offers five ways to stop abandoning projects and finally cross the finish line. -- Read more on ScientificAmerican.com

Novasep invests €10m in commercial aseptic fill/finish facility

Novasep is investing â10m ($11.88) in a commercial fill/finish facility for viral vectors, mAbs, and other low-volume biologics, as part of its plan to double in size by 2022.

Fujifilm expands fill/finish services for gene therapies in Texas

Fujifilm Diosynth Biotechnologies has added fill/finish capabilities for late-phase and commercial supply of gene therapies and viral vaccines.

CMO Rentschler signs Ultragenyx fill/finish deal for US supply

Ultragenyx Pharmaceutical is transferring fill/finish activities for Mepsevvi from Rentschler Biopharmaâs facility in Germany, to Rentschler Fill Solutions in Austria.

Vical Faced With Failure of Another Vaccine Trial

Company will focus on getting oral anti-fungal candidate VL-2397 over the finish line, after another pipeline blow-up.   

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments

An estimated 15 million people in the United States have allergies to more than 170 different foods, according to the non-profit Food Allergy Research and Education. New health data suggests the frequency of food allergies in children under 18 has risen 70 percent since 1997, CNBC reported.

Fujifilm Expands Fill Finish Services

Fujifilm Diosynth Biotechnologies extended its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply. Fujifilm has invested in Vanrx Pharmasystems’ SA25 Aseptic Filling Workcell gloveless isolator technology with automated environmental monitoring and no glass to glass contact.   Fujifilm...

Symbiosis gets FDA approval for manufacturing fill/finish process

Symbiosis recently hosted a successful inspection by the FDA for the aseptic manufacture of viral vector products for commercial supply into the U.S market at its GMP manufacturing The post Symbiosis gets FDA approval for manufacturing fill/finish process appeared first on Pharma Business review.

Fujifilm CDMO Expands Fill/Finish Services

NewsThe fill/finish services offer rapid changeover between drug products and containers, production predictability, and the ability to scale up to support commercial production, even when filling and stoppering complex drug products.

Eerste vrijgave Michter's US*1 Toasted Barrel Finish Bourbon in drie jaar

LOUISVILLE, Kentucky, 22 augustus 2018 /PRNewswire/ -- Michter's Distillery, gevestigd in Louisville, Kentucky, zorgt voor de eerste vrijgave van haar innovatieve US*1 Toasted Barrel Finish Read more...

Fujifilm Expands Fill/Finish Services To Include Late Phase Gene Therapies And Vaccines

NewsThe fill/finish services offer rapid changeover between drug products and containers, production predictability, and the ability to scale up to support commercial production, even when filling and stoppering complex drug products.

Passage of Sports Medicine Clarity Act Improves Care for All Athletes

ROSEMONT, Ill. (PRWEB) October 05, 2018 The American Orthopaedic Society for Sports Medicine ( AOSSM ) is proud to have been part of the process to cross the finish line with the passage of the Sports Medicine Licensure Clarity Act (H.R.302) which was signed into law this week as part of the...

Regeneron's Less Frequent Eylea Dosing Makes Late Sprint Across FDA Finish Line

Regeneron's blockbuster AMD biologic Eylea improved its ability to compete with future longer-acting VEGF inhibitors with a label supporting every...   

Engineering Red Blood Cells to Fight the Most Severe Cancers

Our very own red blood cells could soon become a treatment for some of the most severe forms of cancer; After a long journey of ups and downs, Erytech is now near the finish line to launch the first red ... This awesome article Engineering Red Blood Cells to Fight the Most Severe Cancers appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks